DexCom, Inc.
DXCM
$75.96
-$6.30-7.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.30% | -28.01% | -40.81% | 11.52% | 23.81% |
| Total Depreciation and Amortization | 20.92% | 14.29% | 7.97% | 14.73% | 19.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.33% | 306.90% | 3.61% | 90.11% | 200.62% |
| Change in Net Operating Assets | -66.86% | -97.89% | 102.48% | -90.31% | 44.44% |
| Cash from Operations | 8.45% | -12.14% | 125.60% | -25.89% | 46.82% |
| Capital Expenditure | -42.36% | -52.90% | -137.33% | -120.63% | -12.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 124.84% | 42.14% | -138.32% | 349.03% | 75.29% |
| Cash from Investing | 66.33% | 33.96% | -173.20% | 217.16% | 66.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 5.97% | -- | 3.50% | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.43% | 80.46% | -132.65% | -8.33% | 98.63% |
| Cash from Financing | -21.43% | 165.96% | 99.75% | -15.55% | -100.15% |
| Foreign Exchange rate Adjustments | 1,750.00% | 160.53% | -283.61% | 345.71% | 54.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 188.54% | 4.88% | 80.47% | 42.29% | -84.59% |